pubmed-article:20656316 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20656316 | lifeskim:mentions | umls-concept:C0024314 | lld:lifeskim |
pubmed-article:20656316 | lifeskim:mentions | umls-concept:C0032005 | lld:lifeskim |
pubmed-article:20656316 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
pubmed-article:20656316 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:20656316 | pubmed:dateCreated | 2010-10-18 | lld:pubmed |
pubmed-article:20656316 | pubmed:abstractText | Posttransplantation lymphoproliferative disorders (PTLD) are heterogeneous lesions with variable morphology, immunophenotype, and molecular characteristics. Multiple distinct primary lesions can occur in PTLD, rarely with both B-cell and T-cell characteristics. Lesions can involve both grafted organs and other sites; however, PTLD involving the pituitary gland has not been previously reported. We describe a patient who developed Epstein-Barr virus-negative PTLD 13 years posttransplantation involving the terminal ileum and pituitary, which was simultaneously involved by a pituitary adenoma. Immunohistochemistry of the pituitary lesion showed expression of CD79a, CD3, and CD7 with clonal rearrangements of both T-cell receptor gamma chain (TRG@) and immunoglobulin heavy chain (IGH@) genes. The terminal ileal lesion was immunophenotypically and molecularly distinct. This is the first report of pituitary PTLD and illustrates the potentially complex nature of PTLD. | lld:pubmed |
pubmed-article:20656316 | pubmed:language | eng | lld:pubmed |
pubmed-article:20656316 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20656316 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20656316 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20656316 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20656316 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20656316 | pubmed:month | Nov | lld:pubmed |
pubmed-article:20656316 | pubmed:issn | 1532-8392 | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:BaggAdamA | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:RobbinsMark... | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:BullockGrant... | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:CathroHelen... | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:LopesM... | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:CousarJohn... | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:BonattiHugoH | lld:pubmed |
pubmed-article:20656316 | pubmed:author | pubmed-author:MeridenZinaZ | lld:pubmed |
pubmed-article:20656316 | pubmed:copyrightInfo | Copyright © 2010 Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:20656316 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20656316 | pubmed:volume | 41 | lld:pubmed |
pubmed-article:20656316 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20656316 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20656316 | pubmed:pagination | 1641-5 | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:meshHeading | pubmed-meshheading:20656316... | lld:pubmed |
pubmed-article:20656316 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20656316 | pubmed:articleTitle | Posttransplantation lymphoproliferative disease involving the pituitary gland. | lld:pubmed |
pubmed-article:20656316 | pubmed:affiliation | Department of Pathology, University of Virginia Health System, PO Box 800214, Charlottesville, VA 22908, USA. | lld:pubmed |
pubmed-article:20656316 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20656316 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:20656316 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |